Login




Rebound of disease activity after discontinuation of natalizumab or fingolimod can be successfully treated with autologous haematopoietic stem cell transplantation.

Daniela Currò

Download PDF
Realizzazione: TESISQUARE®

Per assistenza scrivere al Supporto Tecnico